Chapter 4: Health, Medications and Medical Management

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

The foundation of effective care begins with thorough assessment of medical history, pre-existing conditions, and injury circumstances to establish baseline health status and identify risk factors for complications. Safe medication administration follows established protocols including verification of correct medication, patient identification, dosage, route of administration, and timing to prevent errors in care settings. Medical complications are organized by organ system to facilitate recognition and reporting by direct care staff. Cardiopulmonary complications affect approximately one-third of brain injury survivors, including aspiration pneumonia from impaired swallowing reflexes and hypertension requiring medication management. Musculoskeletal complications encompass undiagnosed fractures, peripheral nerve injuries, involuntary muscle tension known as spasticity, and heterotopic ossification, an abnormal bone formation in soft tissues causing pain and functional limitations particularly in hip and elbow regions. Integumentary complications involve pressure ulcers developing over bony prominences from immobility and poor positioning. Gastrointestinal dysfunction includes dysphagia and increased metabolic demands. Elimination system damage produces neurogenic bladder and bowel dysfunction requiring structured retraining programs. Neurological complications include persistent headaches, motor deficits, hydrocephalus, and seizures occurring in five percent of cases but more frequently in severe injuries, including partial seizures affecting one hemisphere and generalized seizures affecting both hemispheres, with status epilepticus representing a medical emergency. Pharmacological management addresses cognitive recovery through stimulants and antiparkinsonian agents to enhance arousal and attention, and neurobehavioral symptoms including agitation, aggression, and anxiety through anticonvulsants, selective serotonin reuptake inhibitors, and atypical antipsychotics, following a conservative approach of starting with low doses and modifying one medication at a time. Substance abuse complicates approximately forty percent of post-acute rehabilitation cases, with alcohol predominance, increasing risks of secondary brain injury. Finally, the chapter addresses long-term aging concerns, noting that brain injury may accelerate cerebral aging and increase Alzheimer's disease risk in long-term survivors.